http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
-
Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results
-
Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
-
Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4
-
Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase
-
Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference
-
Rapid Micro Biosystems Reports Second Quarter 2023 Financial Results
-
Rapid Micro Biosystems to Announce Second Quarter 2023 Financial Results on August 4, 2023
-
Rapid Micro Biosystems (RPID) Appoints Kirk Malloy as Board Chair
-
Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors
-
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rapid Micro Biosystems Reports First Quarter 2023 Financial Results
-
Rapid Micro Biosystems Announces the Appointment of Michael Wysocki as Senior Vice President, Sales and Marketing
-
Rapid Micro Biosystems to Announce First Quarter 2023 Financial Results on May 5, 2023
-
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance
-
Rapid Micro Biosystems to Participate in the Cowen 43rd Annual Health Care Conference
-
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023
-
Rapid Micro Biosystems (RPID) Reports Prelim Q4 and FY22 Revenue
-
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue
-
Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference
-
Rapid Micro Biosystems (RPID) Announces Publication of Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology
-
Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology
-
Rapid Micro Biosystems (RPID) Concludes Review of Strategic Alternatives, No Parties Submitted Binding Offers
-
Rapid Micro Biosystems Concludes Review of Strategic Alternatives
-
Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results
-
Rapid Micro Biosystems to Announce Third Quarter 2022 Financial Results on November 10, 2022
-
Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System
-
Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference
-
Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference
-
Rapid Micro Biosystems (RPID) Announces Review of Strategic Alternatives, Adoption of Stockholder Rights Plan
-
Rapid Micro Biosystems Provides Business Update and Reports Second Quarter 2022 Financial Results
-
Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value
-
Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022
-
Rapid Micro Biosystems (RPID) Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management
-
Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management
-
Rapid Micro Biosystems Reports First Quarter 2022 Financial Results
-
Rapid Micro Biosystems to Announce First Quarter 2022 Financial Results on May 10, 2022
-
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2021 Financial Results and Reaffirms Full Year 2022 Guidance
-
Rapid Micro Biosystems to Participate at the Cowen 42nd Annual Health Care Conference
-
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2021 Financial Results on March 4, 2022
-
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
-
Spot Mobile International Ltd. (RPID) Reports Prelim Q4 Results; Issues 2022 Guidance
-
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook
-
Rapid Micro Biosystems, Inc (RPID) Appoints Inese Lowenstein to its Board
-
Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors
-
Rapid Micro Biosystems Reports Third Quarter 2021 Financial Results
-
Rapid Micro Biosystems to Present at Stifel 2021 Virtual Healthcare Conference
-
Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021
-
Rapid Micro Biosystems Announces Appointment of Andy Keys as Chief Commercial Officer
-
Rapid Micro Biosystems to Exhibit at the 2021 PDA Pharmaceutical Microbiology Conference on October 4-6

